BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9072002)

  • 1. Nuclear morphometry as a predictor of disease outcome in gastric cancer.
    Setälä L; Lipponen P; Kosma VM; Marin S; Eskelinen M; Syrjänen K; Alhava E
    J Pathol; 1997 Jan; 181(1):46-50. PubMed ID: 9072002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear profiles of cancer cells reveal the metastatic potential of gastric cancer.
    Ikeguchi M; Cai J; Oka S; Gomyou Y; Tsujitani S; Maeta M; Kaibara N
    J Pathol; 2000 Sep; 192(1):19-25. PubMed ID: 10951395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The significance of nuclear morphometric variables as prognostic predictors in breast cancer.
    Aaltomaa S; Lipponen P; Eskelinen M; Kosma VM; Marin S; Alhava E; Syrjänen K
    Anticancer Res; 1991; 11(4):1663-9. PubMed ID: 1746922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of classic and quantitative prognostic factors in colorectal cancer.
    Ropponen K; Eskelinen M; Kosma VM; Lipponen P; Paakkinen P; Alhava E
    Anticancer Res; 1996; 16(6B):3875-82. PubMed ID: 9042274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer in young women: clinical, histological and morphometric prognostic factors.
    Eskelinen M; Lipponen P; Aaltomaa S; Kosma VM; Syrjänen K; Alhava E
    Anticancer Res; 1992; 12(4):1237-42. PubMed ID: 1503415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphometry of gastric carcinoma: its association with patient survival, tumour stage, and DNA ploidy.
    Hamilton PW; Wyatt JI; Quirke P; Watt PC; Arthur K; Ward DC; Johnston D
    J Pathol; 1992 Oct; 168(2):201-8. PubMed ID: 1460537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of morphometric nuclear grade of endometrial carcinoma.
    Salvesen HB; Iversen OE; Akslen LA
    Cancer; 1998 Sep; 83(5):956-64. PubMed ID: 9731900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear morphometry in prognostication of breast cancer in Saudi Arabian patients: comparison with European and African breast cancer.
    Buhmeida A; Al-Maghrabi J; Merdad A; Al-Thubaity F; Chaudhary A; Gari M; Abuzenadah A; Collan Y; Syrjänen K; Al-Qahtani M
    Anticancer Res; 2010 Jun; 30(6):2185-91. PubMed ID: 20651368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of nuclear morphometry of breast cancer in histological sections with clinicopathological features and prognosis.
    Abdalla F; Boder J; Markus R; Hashmi H; Buhmeida A; Collan Y
    Anticancer Res; 2009 May; 29(5):1771-6. PubMed ID: 19443402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is tumor size a prognostic indicator for gastric carcinoma?
    Yokota T; Ishiyama S; Saito T; Teshima S; Yamada Y; Iwamoto K; Takahashi M; Murata K; Yamauchi H
    Anticancer Res; 2002; 22(6B):3673-7. PubMed ID: 12552975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear size as prognostic determinant in stage II and stage III colorectal adenocarcinoma.
    Buhmeida A; Algars A; Ristamäki R; Collan Y; Syrjänen K; Pyrhönen S
    Anticancer Res; 2006; 26(1B):455-62. PubMed ID: 16739305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival predictors in patients with node-negative gastric carcinoma.
    Lee CC; Wu CW; Lo SS; Chen JH; Li AF; Hsieh MC; Shen KH; Lui WY
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1014-8. PubMed ID: 17608847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of colorectal cancer prognosis through nuclear morphometry.
    Eynard HG; Soria EA; Cuestas E; Rovasio RA; Eynard AR
    J Surg Res; 2009 Jun; 154(2):345-8. PubMed ID: 18708194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear morphometry in human pancreatic adenocarcinoma; relation to histological grade, clinical stage, and survival.
    Lipponen P; Eskelinen M; Collan Y
    Ital J Gastroenterol; 1990 Jun; 22(3):124-8. PubMed ID: 1966706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
    Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
    Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive factors for lymph node metastasis in early gastric cancer with submucosal invasion: analysis of a single institutional experience.
    An JY; Baik YH; Choi MG; Noh JH; Sohn TS; Kim S
    Ann Surg; 2007 Nov; 246(5):749-53. PubMed ID: 17968165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paradoxical expression of maspin in gastric carcinomas: correlation with carcinogenesis and progression.
    Yu M; Zheng H; Tsuneyama K; Takahashi H; Nomoto K; Xu H; Takano Y
    Hum Pathol; 2007 Aug; 38(8):1248-55. PubMed ID: 17490717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship between new TNM classification and the prognosis and biological behavior of gastric cancer].
    Wang Z; Xu H; Wang S; Chen J
    Zhonghua Wai Ke Za Zhi; 2000 Jul; 38(7):493-5. PubMed ID: 11832089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear grading of primary pulmonary adenocarcinomas: correlation between nuclear size and prognosis.
    Nakazato Y; Minami Y; Kobayashi H; Satomi K; Anami Y; Tsuta K; Tanaka R; Okada M; Goya T; Noguchi M
    Cancer; 2010 Apr; 116(8):2011-9. PubMed ID: 20151423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffuse type advanced gastric cancer showing dismal prognosis is characterized by deeper invasion and emerging peritoneal cancer cell: the latest comparative study to intestinal advanced gastric cancer.
    Yamashita K; Sakuramoto S; Katada N; Futawatari N; Moriya H; Hirai K; Kikuchi S; Watanabe M
    Hepatogastroenterology; 2009; 56(89):276-81. PubMed ID: 19453074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.